How much of the patients heart failure is due to a treatable thyroid hormone imbalance?

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Cardiology Treatment and Cardiovascular Medicine

Berlin, Germany
How much of the patients heart failure is due to a treatable thyroid hormone imbalance?

The idea of treating heart diseases with thyroid hormones (THs) has been around for over 60 years, but has never been proven or disproven. Many things have contributed to this open question, including: (1) lack of financial incentive; (2) negative effects of several influential clinical studies that actually used an overdose of TH analogs rather than actual THs; and (3) lack of a proven TH treatment/monitoring protocol than can be safely translated to humans. Nonetheless, a growing body of pre-clinical and clinical evidence suggests that we should be asking the following question- “How many of your symptoms are due to the diagnosed heart disease and how many are due to low cardiac tissue TH levels?” Those who have not kept up with recent evidence may be surprised by what we have learned recently. In particular, it now appears that heart diseases in general may trigger low cardiac tissue T3 levels, a condition that by itself has been shown to cause heart failure. THs offer the promise of improving ventricular contraction and relaxation, improving coronary blood flow, inhibiting atherosclerosis, and new results suggest that restoration of cardiac tissue THs may even reduce the incidence of arrhythmias in heart diseases.

Read More

Submit Manuscript

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger